
German pharma firm Merck KGaA has agreed to hand over its CAR-T therapy business to US company Intrexon in a …

Merck Serono has announced a significant deal with Intrexon to develop and bring new cancer treatments to market. The German …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

